App-Quantinova.ai

REDUCTION IN JOINT REPLACEMENT SURGERY IN PATIENTS WITH REUMATOID ARTHRITIS

T. W. Nystad - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Rheumatoid arthritis

Hydroxychloroquine

THE DIFFERENCES BETWEEN EARLY UNDIFFERENTIATED ARTHRITIS PATIENTS ACCORDING TO THE 2010 ACR/EULAR CRITERIA FULFILLED AT THE DISEASE ONSET DO THESE MATTER?

M. M. Tamas - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

EOSINOPHILIC FASCIITIS (SCHULMA-S DISEASE): CLINICAL SPECTRUM, RESPONSE TO TREATMENT AND LONG TERM OUTCOME IN A SERIES OF 18 SPANISH PATIENTS

W. A. Sifuentes Giraldo - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Eosinophilic fasciitis

Hydroxychloroquine

LONGTERM OUTCOMES OF CHILDREN BORN TO MOTHERS WITH SLE EXPOSED TO AZATHIOPRINE IN PREGNANCY

M. Gayed - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Renal disease

Hydroxychloroquine

ONSET AGE INFLUENCES CLINICAL AND LABORATORY PROFILE OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

O. A. Monticielo - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Lupus

Hydroxychloroquine

MESANGIAL PROLIFERATIVE LUPUS NEPHRITIS (ISN/RPS CLASS II): CLINICAL AND PROGNOSIS IN A COHORT OF 45 PATIENTS

G. Albert - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Renal insufficiency

Hydroxychloroquine

THE IMPACT OF PREGNANCY ON LUPUS FLARES IN KOREAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: 15-YEAR EXPERIENCE, SINGLE-CENTER STUDY

J. Koh - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

BLOOD HYDROXYCHLOROQUINE (HCQ) LEVELS DO NOT PREDICT QUALITY OF LIFE IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

M. Jolly - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

SYSTEMIC LUPUS ERYTHEMATOSUS: SURVIVAL ANALYSIS IN PATIENTS FOLLOWED AT A TERTIARY CARE CENTER IN SOUTHERN BRAZIL

A. A. Gasparin - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

DOES THE ADVANCED AGE INFLUENCE ON THE TYPE OF RENAL INJURY AND THE PROGNOSIS OF LUPUS NEPHRITIS?

E. Armengol - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

T-LYMPHOCYTE SUBSETS AND CMV AND EBV DNA IN BLOOD OF SLE PATIENTS AND KIDNEY TRANSPLANT RECIPIENTS

L. Cavagna - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Cytomegalovirus infection

Hydroxychloroquine

PLASMA IL-22 LEVELS CORRELATE WITH TH22 CELLS IN PATIENTS WITH NEW-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS

J. Lin - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

A DELPHI EXERCISE FOR TREATMENT ALGORITHMS FOR SYSTEMIC LUPUS ERYTHEMATOSUS

J. E. Pope - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Antiphospholipid syndrome

Hydroxychloroquine

IMPACT OF TREATMENTS ON MAJOR IMMUNOLOGIC PATHWAYS IN SLE DEPENDS ON TYPE I INTERFERON SIGNATURE: ANALYSIS FROM BIOMARKERS OF LUPUS DISEASE (BOLD) STUDY

J. T. Merrill - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

THE COMPLETE RESPONSE IN PATIENTS WITH LUPUS NEPHRITIS TREATED WITH MYCOPHENOLATE MOFETIL (MMF) AS THEIR FIRST LINE THERAPY

H. Timlin - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Lupus nephritis

Hydroxychloroquine

PULSE CYCLOPHOSPHAMIDE THERAPY OF LUPUS-NEPHRITIS AND ITS COURSE THROUGH THE MAINTENANCE THERAPY

J. Lukac - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

TREATMENT OF INCIDENT SLE, RESULTS FROM THE FINNISH NATIONWIDE REGISTER 2000-2007

P. Elfving - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

Hydroxychloroquine

THE INFLUENCE OF THERAPY ON CD4+CD25HIGHFOXP3+ T REGULATORY CELLS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: A PROSPECTIVE STUDY

K. Tselios - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

ADALIMUMAB SERUM CONCENTRATIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS OR PSORIATIC ARTHRITIS TAKING CONCOMITANT DMARD THERAPY

C. Krieckaert - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Rheumatoid arthritis

Hydroxychloroquine

SYSTEMIC LUPUS ERYTHEMATOSUS AND THE ANTIPHOSPHOLIPID SYNDROME

R. Derksen - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Immune thrombocytopenia

Hydroxychloroquine

Filters

1151 Abstracts